Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2025-07-11

FDA Approved: TESTOSTERONE CYPIONATE — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approves a supplemental application for TESTOSTERONE CYPIONATE (Hospira, Inc.), resulting in labeling changes for this testosterone replacement therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Testosterone cypionate (testosterone cypionate)

Snippet

SUPPL AP for TESTOSTERONE CYPIONATE (TESTOSTERONE CYPIONATE)